Beijing Tiantan Biological Products Co., Ltd. (SHA: 600161)
China flag China · Delayed Price · Currency is CNY
21.86
+0.15 (0.69%)
Nov 19, 2024, 3:00 PM CST

Beijing Tiantan Biological Products Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
5,2135,1624,2444,1123,4343,274
Upgrade
Other Revenue
18.3818.3816.86-11.288.13
Upgrade
Revenue
5,2325,1804,2614,1123,4463,282
Upgrade
Revenue Growth (YoY)
-2.59%21.57%3.63%19.35%4.99%11.97%
Upgrade
Cost of Revenue
2,3462,5532,1722,1591,7511,657
Upgrade
Gross Profit
2,8862,6282,0891,9541,6951,625
Upgrade
Selling, General & Admin
680.05739.98627.83599.41491.34451.9
Upgrade
Research & Development
180.3139.95122.01133.21118.61116.79
Upgrade
Other Operating Expenses
38.5842.3744.9247.0636.0634.42
Upgrade
Operating Expenses
895.13921.65796.02779.55646.18603.26
Upgrade
Operating Income
1,9911,7061,2931,1741,0491,021
Upgrade
Interest Expense
-3.42-3.65-2.41-3.09-2.98-
Upgrade
Interest & Investment Income
93.7592.7490.1980.9235.8623.6
Upgrade
Currency Exchange Gain (Loss)
000.01-0-0.13-0.13
Upgrade
Other Non Operating Income (Expenses)
-4.51-5.01-0.7-3.05-1.22-2.97
Upgrade
EBT Excluding Unusual Items
2,0771,7901,3801,2491,0801,042
Upgrade
Gain (Loss) on Sale of Assets
-0.99-1.0413.55-0.3-0.62-0.5
Upgrade
Asset Writedown
-1.42-0.22-0.03-14.28-0.06-0.48
Upgrade
Other Unusual Items
7.489.6532.636.7725.182.5
Upgrade
Pretax Income
2,0821,7991,4261,2411,1051,043
Upgrade
Income Tax Expense
352.75289.14221.6172.2161.8149.19
Upgrade
Earnings From Continuing Operations
1,7291,5091,2051,069943.08894.25
Upgrade
Minority Interest in Earnings
-455.03-399.57-323.76-308.8-304.07-283.16
Upgrade
Net Income
1,2741,110880.92760.01639.01611.09
Upgrade
Net Income to Common
1,2741,110880.92760.01639.01611.09
Upgrade
Net Income Growth
9.14%25.99%15.91%18.94%4.57%19.94%
Upgrade
Shares Outstanding (Basic)
1,9971,9881,9941,9401,8061,796
Upgrade
Shares Outstanding (Diluted)
1,9971,9881,9941,9401,8061,796
Upgrade
Shares Change (YoY)
1.32%-0.32%2.79%7.41%0.59%-0.04%
Upgrade
EPS (Basic)
0.640.560.440.390.350.34
Upgrade
EPS (Diluted)
0.640.560.440.390.350.34
Upgrade
EPS Growth
7.72%26.40%12.76%10.73%3.95%19.99%
Upgrade
Free Cash Flow
269.831,316-228.02-151.3593.2116.24
Upgrade
Free Cash Flow Per Share
0.140.66-0.11-0.080.050.06
Upgrade
Dividend Per Share
0.1250.1250.0420.0690.0690.035
Upgrade
Dividend Growth
199.76%199.76%-39.91%0%99.43%44.40%
Upgrade
Gross Margin
55.17%50.72%49.02%47.51%49.19%49.50%
Upgrade
Operating Margin
38.06%32.93%30.34%28.55%30.44%31.12%
Upgrade
Profit Margin
24.36%21.42%20.67%18.48%18.55%18.62%
Upgrade
Free Cash Flow Margin
5.16%25.40%-5.35%-3.68%2.71%3.54%
Upgrade
EBITDA
2,3011,9511,4521,3131,1821,150
Upgrade
EBITDA Margin
43.99%37.67%34.07%31.92%34.29%35.03%
Upgrade
D&A For EBITDA
310.33245.36158.74138.65132.75128.21
Upgrade
EBIT
1,9911,7061,2931,1741,0491,021
Upgrade
EBIT Margin
38.06%32.93%30.34%28.55%30.44%31.12%
Upgrade
Effective Tax Rate
16.94%16.08%15.54%13.88%14.64%14.30%
Upgrade
Revenue as Reported
5,2325,1804,2614,1123,4463,282
Upgrade
Advertising Expenses
-1.635.266.357.41-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.